Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung Cancer
Clinical trial NCT03502850 · UNKNOWN
Trial details
- NCT number
- NCT03502850
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2021-01-01
- Enrollment
- 507
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.